Skip to main content
Clinical Trials/ACTRN12614000674639
ACTRN12614000674639
Recruiting
未知

Terminal ProB-Type Natriuretic Peptide and Late Pulmonary Hypertension Secondary to Chronic Lung Disease in Premature Infants Born at Less Than 30 Weeks Gestation

niversity of Otago0 sites50 target enrollmentJune 26, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Pulmonary Hypertension/pulmonary vascular disease
Sponsor
niversity of Otago
Enrollment
50
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 26, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Infants born at \< 30 weeks gestation and cared for at Christchurch Women's Hospital NICU.

Exclusion Criteria

  • Known structural airway or lung anomalies, congenital anomalies of the pulmonary arteries or pulmonary veins, major systemic to pulmonary artery collateral vessels, congenital heart disease(except those with patent ductus arteriosus, patent foramen oval or atrial septal defect), severe liver disease and persistent pulmonary hypertension of the newborn (from birth).

Outcomes

Primary Outcomes

Not specified

Similar Trials